The results indicated that high expression of CCDC86 in gliomas was associated with poor overall survival (Logrank_P = 1.77E-19; hazard ratio = 2.19 (1.84–2.6) (Fig. 1E). The gene discussed is CCDC86; the disease is central nervous system cancer.